Is TARA stock safe? | Glauxie AI

Q: Is TARA stock safe?

Protara Therapeutics, Inc. (TARA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jesse Shefferman. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's... Employees: 51.

Q: What are the risks of investing in TARA?

Identify key risks of investing in TARA — debt, competition, volatility, and sector headwinds.

Q: Is TARA a good long-term investment?

Evaluate TARA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does TARA have?

Review TARA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is TARA stock safe?

🦉

Protara Therapeutics, Inc. (TARA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJesse Shefferman

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic...

Key Executives

Name	Title
Carla Beckham	Lead Medical Director, Head of Clinical Development of TARA-002 in NMIBC & Board-Certified Urologist
Hannah Fry	Vice President, Principal Accounting Officer & Controller
Jacqueline Zummo	Co-Founder, Chief R&D Officer
Jesse Shefferman	Co-founder, Chief Executive Officer, President & Director
Justine O'Malley	Senior Vice President of Investor Relations & Corporate Affairs
Leonardo Viana Nicacio	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TARA Profile Financials

What are the risks of investing in TARA? Is TARA a good long-term investment? How much debt does TARA have?